This site is intended for health professionals only

Swine flu detection kit set for EU

teaser

A test that differentiates the H1N1 virus from two seasonal flu strains will soon be used in Europe, a pharmaceutical company has announced.

Drug giant Gen-Probe said that ProFlu-ST assay had received its CE (Conformite Europeenne) Mark, enabling it to be sold in the EU.

The test uses a molecular technique called polymerase chain reaction to identify three forms of the flu virus – 2009 H1N1 influenza, influenza A/H1 and influenza A/H3.

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

Steve Kondor, Gen-Probe’s senior vice president of sales and marketing, said: “Many experts expect continued high levels of 2009 H1N1 infections this flu season, along with a return of either or both of the seasonal flu strains, so we believe the ability of the ProFlu-ST assay to differentiate among the strains can help physicians provide personalized care.”

The test can be used in conjunction with ProFlu+ assay, which was CE-marked in 2007.

Copyright Press Association 2009

Gen-Probe






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x